Overexpression of elafin in ovarian carcinoma is driven by genomic gains and activation of the nuclear factor kappaB pathway and is associated with poor overall survival

卵巢癌中 elafin 的过度表达是由基因组增益和核因子 κB 通路的激活所驱动的，并且与总体生存率较低有关